|
 |
Medical > Retina News
You are currently reading Medical > Retina news, below you will find the latest Retina news available at Medical. For more general Retina information please visit Retina. Retina is categorized in the R index of Medical.
Bayer HealthCare and Regeneron Announce VEGF Trap-Eye Achieved... Study patients, on average, received only two additional doses following a 12-week fixed dosing period Leverkusen, Germany and Tarrytown, NY.- Bayer HealthCare AG and Regeneron Pharmaceuticals, Inc. OpenClinica EDC Solution Deployed for Retina Implant Studies The company's primary product is a novel retinal prosthesis that in many ways is analogous to the popular cochlear implant used as a hearing prosthesis. Regeneron and Bayer HealthCare announce vision improvement in... Regeneron and Bayer HealthCare announce vision improvement in patients with age-related macular degeneration in phase II study Published in M2Europharma on Wednesday, 20 August 2008 at 07:17 GMT 19 August 2008 ... Technology opens up new prospects for the blind Swiss President Pascal Couchepin tries out a tactile map for the blind developed by Geneva engineering students Tactile street maps, a computer mouse to learn Braille and a mobile phone that reads written text ... ForeScout Partners With eEye Digital Security ForeScout Technologies, a provider access control and policy management solutions, and eEye Digital Security, a supplier of integrated security and threat management solutions, announced a teaming relationship ... Regeneron Pharmaceuticals, Inc. and Bayer HealthCare AG Announce VEGF ... Regeneron Pharmaceuticals, Inc. and Bayer HealthCare AG Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over 52 Weeks in a Phase 2 Study in Patients with Age-Related Macular Degeneration 8/19/2008 ... Valley diabetes rates triple the national average More than one in five people in the Rio Grande Valley has diabetes - about three times the national rate, officials said Monday. Regeneron and Bayer HealthCare Announce VEGF Trap-Eye Achieved... Study patients, on average, received only two additional doses following a 12-week fixed dosing period TARRYTOWN, N.Y. & LEVERKUSEN, Germany-- --Regeneron Pharmaceuticals, Inc. Hood-to-Coast more popular than ever Thousands of runners from around the U.S. and the world will compete in the 2008 Hood-to-Coast relay. Age-Related Macular Degeneration Age-related macular degeneration is a condition that affects the light-sensitive cells in the central area of the eye's retina, called the macula. |
Medical Topics
Everything you need to know about Medical
Medical
If you know the Medical Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Medical.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.